MeSH D034161 - pelvic infection
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Ceftriaxone | Ceftriaxone |  | 2007-03-15 |  |  |
| Roche | Ceftriaxone, Lidocaine | Rocephin |  | 1985-03-12 | $261.442 M | Y2021 |
| Lupin Research | Ceftriaxone | Ceftriaxone |  | 2003-09-30 |  |  |
| Sandoz | Ceftriaxone | Ceftriaxone |  | 2005-05-17 |  |  |
| Merck & Co | Ertapenem | Invanz |  | 2001-11-21 | $189 M | Y2022 |
| Aurobindo Pharma | Ceftriaxone | Ceftriaxone |  | 2008-07-31 |  |  |
| Sun Pharmaceutical Industries | Ertapenem | Ertapenem SUN |  | 2022-07-15 |  |  |
| Ertapenem | Ertapenem |  | 2023-05-02 |  |  | |
| Hospira | Ceftriaxone | Ceftriaxone |  | 2005-08-02 |  |  |
| Wockhardt | Ceftriaxone | Ceftriaxone |  | 2006-05-12 |  |  |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/3
Phase 3
100%4/4
Approved: 4Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use